CONCORD DRUGS
Back to Balance Sheet
|
CONCORD DRUGS Last 5 Year Total Non-Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Total Non-Current Assets | ₹24 Cr | ₹21 Cr | ₹15 Cr | ₹15 Cr |
What is the latest Total Non-Current Assets ratio of CONCORD DRUGS ?
| Year | Total Non-Current Assets |
|---|---|
| Mar2025 | ₹24 Cr |
| Mar2024 | ₹21 Cr |
| Mar2023 | ₹15 Cr |
| Mar2022 | ₹15 Cr |
How is Total Non-Current Assets of CONCORD DRUGS Trending?
| Years | Total Non-Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹24 Cr | 14.52 | |
| Mar2024 | ₹21 Cr | 44.09 | |
| Mar2023 | ₹15 Cr | 1.51 | |
| Mar2022 | ₹15 Cr | - | |
Compare Total Non-Current Assets of peers of CONCORD DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD DRUGS | ₹93.8 Cr | 1.4% | -6.3% | 10.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹468,842.0 Cr | -0.4% | 4.3% | 13.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹193,860.0 Cr | 0.9% | 8.9% | 8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹192,687.0 Cr | 0.7% | 13% | 46.5% | Stock Analytics | |
| CIPLA | ₹112,593.0 Cr | -1% | -0% | -3.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,364.9 Cr | -3.3% | -8.4% | -4.3% | Stock Analytics | |
CONCORD DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD DRUGS | 1.4% |
-6.3% |
10.7% |
| SENSEX | -1% |
-0.9% |
-7.5% |
You may also like the below Video Courses